Blood Sugar Control After Weight-Loss Surgery
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests whether a diabetes medication called dapagliflozin helps smooth out blood sugar swings after bariatric (weight-loss) surgery. It may help people with type 2 diabetes achieve better control after their surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Type 2 diabetes, either before or after bariatric surgery
- Blood sugar (HbA1c) not severely high (≤10.5%)
- No type 1 diabetes, secondary diabetes, or history of ketoacidosis
- No severe kidney disease, active eye complications, or recent cancer (within 5 years)
- Not pregnant, breastfeeding, or planning pregnancy
- Not taking insulin or certain other diabetes pills; no allergy to dapagliflozin or similar drugs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a specific type of weight loss surgery can help people with type 2 diabetes stop needing diabetes medication. It is for people with a very high body mass index (BMI over 45) who are currently on diabetes pills or insulin.
This trial tests a medication called mizagliflozin to see if it can reduce episodes of low blood sugar in people who have had gastric bypass surgery. If you experience symptoms like confusion or fainting when your blood sugar drops, this study might help.
This study compares two diabetes medications, dapagliflozin and empagliflozin, to see which is more effective, safe, and affordable for people with type 2 diabetes and a high body weight. Both medications help lower blood sugar and may also help with weight loss.
This trial looks at whether a specific diabetes medicine given after bariatric (weight-loss) surgery can improve blood sugar control in people with type 2 diabetes. You might be considered if you are eligible for this surgery and meet the weight criteria.
This trial tests whether a diabetes medication called dapagliflozin can help improve how well the right side of your heart works after off-pump coronary artery bypass grafting surgery (a way to reroute blood around blocked heart arteries). The goal is to see if this drug reduces strain on your heart during recovery.
This study looks at how gut hormones and blood sugar control change after Roux-en-Y gastric bypass. It may help researchers understand what supports healthier glucose levels after bariatric surgery.
Hear when a new Bariatric Surgery Candidate trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.